International Clinical Trial Day and clinical trials in Ethiopia and Africa

被引:0
作者
Abebaw Fekadu
Solomon Teferra
Asrat Hailu
Tsige Gebre-Mariam
Adamu Addissie
Wakgari Deressa
Getnet Yimer
Ahmed Reja
机构
[1] Addis Ababa University,Department of Psychiatry, School of Medicine, College of Health Sciences
[2] Institute of Psychiatry,Department of Psychological Medicine, Centre for Affective Disorders
[3] King’s College London,Department of Microbiology, School of Medicine, College of Health Sciences
[4] Addis Ababa University,Regional Bioequivalence Center, College of Health Sciences
[5] Addis Ababa University,School of Public Health, College of Health Sciences
[6] Addis Ababa University,Department of Pharmacology, School of Medicine, College of Health Sciences
[7] Addis Ababa University,College of Health Sciences
[8] Addis Ababa University,undefined
来源
Trials | / 15卷
关键词
Clinical trial; Developing country; Africa; Ethiopia; Trial registration;
D O I
暂无
中图分类号
学科分类号
摘要
Low income countries like Ethiopia are underrepresented in clinical research. As a major public commitment to clinical research, Ethiopia celebrated the International Clinical Trial Day (ICTD) for the first time on 20 May 2014 under the auspices of Addis Ababa University. The motto for the day was ‘Clinical Trials for Excellence in Patient Care’. The celebration offered an opportunity to inform academic staff, researchers, students and the leadership about clinical trials being conducted and to discuss the future of clinical trials in the country. Although clear challenges to the conduct of trials abound, clinical trials registered from Ethiopia in trial registration databases is increasing. Cross-country collaborations, international funding support, motivation of academic staff to conduct clinical trials and the commitment and engagement of the leadership in research are all improving. The overall impact of clinical trials is also encouraging. For example, some of the trials conducted in Ethiopia have informed treatment guidelines. However, administrative capacity, research infrastructure as well as financial support remain weak. There is a need for enhanced university-industry linkage and translation of research findings into locally relevant evidence. Ethiopia, as well as the whole of Africa, has an unparalleled opportunity to lead the way in clinical trials, given its prospect of development and the need to have locally relevant evidence for its growing population. In this commentary we reflect on the celebration of ICTD, the status and opportunities for conducting clinical trials and the way forward for facilitating clinical trials in Ethiopia and Africa.
引用
收藏
相关论文
共 89 条
[1]  
Donnelly J(2011)Ethiopia gears up for more major health reforms Lancet 377 1907-1908
[2]  
Musa A(2012)Sodium Stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial PLoS Negl Trop Dis 6 e1674-4104
[3]  
Khalil E(2014)High parasitological failure rate of visceral leishmaniasis to Sodium Stibogluconate among HIV Co-infected adults in Ethiopia PLoS Negl Trop Dis 8 e2875-294
[4]  
Hailu A(2013)Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial Trials 14 406-1555
[5]  
Olobo J(2014)A placebo-controlled trial of folate with B12 in patients with schizophrenia with residual symptoms in Ethiopia using a sequential parallel comparison design Br J Med Res 4 4090-undefined
[6]  
Balasegaram M(2013)Six pairs of things to celebrate on International clinical trials day Trials 14 128-undefined
[7]  
Omollo R(2006)Visceral leishmaniasis in the New World & Africa Indian J Med Res 123 289-undefined
[8]  
Edwards T(2012)How big is the next big thing? Estimating the burden of non–communicable diseases in low–and middle–income countries J Global Health 2 020101-undefined
[9]  
Rashid J(2011)Clinical research: time for sensible global guidelines Lancet 377 1553-undefined
[10]  
Mbui J(2013)Understanding the investigators: a qualitative study investigating the barriers and enablers to the implementation of local investigator-initiated clinical trials in Ethiopia BMJ Open 3 e003616-undefined